5DisSaneevate P,W arne G ,Zacharin M. J Pediatr Endocrinol Metab, 1998,11(5) :63 1 -638.
6Besma Ayari & Nadia Soussi - Yanicostas. FGFRI and anosmin - 1 underlying genetically distinct forms of Kallmann syndrome are coexpressed and interact in olfactory bulbs. Dev Genes Evol (2007) 217:169 - 175.
7Duke VM, Winyard PJD, Thorogood P,et al. KAL, a gene mutated in Kallmanng syndrome, is expressed in the first trimester of human development. Mol Cell Endocrinol, 1995,110:73 - 79.
8Tsai PS, Gill J. Mechanisms of disease: insights into X - linked and autosomal dominant Kallmann syndrome. Nat Clin Pract Endocrinol Metab,2006,2 : 160 - 171.
9CANTO P, Mungui A. Genetic Analysis in Patients With Kallmann Syndrome:Coexistence of Mutations in Prokineticin Receptor 2 and KALI. Journal of Andrology, Vol. 30, No. 1, January/February, 2009,30:41 -45.
10Suhandy Tengara, Mitsutoshi Tominaga,et al. Keratinoeyte- derived anosmin - 1, an extracellular glycoprntein encoded by the X - linked Kallmann syndrome gene, is involved in modulation of epidermal nerve density in atopic dermatitis. Journal of Dermatological Science, 2010,58:64-71.
